Cresco Labs Inc. to Post Q2 2022 Earnings of $0.01 Per Share, Echelon Wealth Partners Forecasts (OTCMKTS:CRLBF)

Cresco Labs Inc. (OTCMKTS:CRLBFGet Rating) – Research analysts at Echelon Wealth Partners issued their Q2 2022 earnings estimates for Cresco Labs in a research note issued on Wednesday, May 18th. Echelon Wealth Partners analyst A. Semple forecasts that the company will earn $0.01 per share for the quarter. Echelon Wealth Partners currently has a “Buy” rating on the stock. Echelon Wealth Partners also issued estimates for Cresco Labs’ Q3 2022 earnings at $0.03 EPS, Q4 2022 earnings at $0.03 EPS, FY2022 earnings at $0.00 EPS and FY2023 earnings at $0.28 EPS.

CRLBF has been the topic of several other reports. Alliance Global Partners dropped their target price on shares of Cresco Labs from C$19.00 to C$15.00 in a report on Thursday. Zacks Investment Research downgraded shares of Cresco Labs from a “hold” rating to a “sell” rating in a report on Monday, May 9th. Canaccord Genuity Group dropped their target price on shares of Cresco Labs from C$12.00 to C$9.50 in a report on Thursday. Piper Sandler lowered their price objective on shares of Cresco Labs from $14.00 to $9.00 and set an “overweight” rating on the stock in a report on Thursday, March 24th. Finally, Atb Cap Markets reiterated an “outperform” rating on shares of Cresco Labs in a report on Wednesday, March 23rd. One investment analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $16.79.

Shares of CRLBF stock opened at $4.09 on Monday. The company’s 50 day moving average price is $5.21 and its two-hundred day moving average price is $6.48. Cresco Labs has a 52 week low of $3.80 and a 52 week high of $12.88.

Cresco Labs Company Profile (Get Rating)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand.

Featured Articles

Earnings History and Estimates for Cresco Labs (OTCMKTS:CRLBF)

Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.